ºÚÁÏÍø

ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 2091

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Aldose reductase inhibitors of plant origin in the treatment and prevention of fatty liver disease

14th Annual Congress on Gastroenterology & Hepatology

Longxin Qiu

Longyan University, China

Posters & Accepted Abstracts: J Gastrointest Dig Syst

DOI:

Abstract
Fatty Liver Disease (FLD) is a growing public health problem worldwide. The requirement for alternative and natural medicine has been increasing rapidly and considerably. Recently, Aldose Reductase (AR)/polyol pathway has been reported to be involved in the development of FLD, therefore it is of interest to study the effect of plant-derived AR inhibitors on FLD. By conducting some investigations and by reading through literatures regarding AR inhibitors and FLD, we propose that plant-derived AR inhibitors may block AR/polyol pathway and in turn reduce the fructose production and the subsequent fat accumulation in liver in diabetic or high glucose diet-fed mice. Moreover, we propose that in rodents with alcoholic liver disease or non-alcoholic fatty liver disease/nonalcoholic steatohepatitis, AR inhibitors may improve PPARα-mediated fatty acid oxidation and reduce hepatic steatosis, and may attenuate CYP2E1-mediated oxidative stress or AR/gut bacterial endotoxinmediated cytokines overproduction to alleviate progression of FLD. We conclude that potent AR inhibitors of plant origin may be efficient drugs for the treatment and prevention of FLD.
Biography

E-mail: 1923015106@

 

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top